Various clinicopathological features (e.g., tumor size and pathological stage and TNM stages) are significantly associated with overexpressed KIF11, which has been revealed in a series of cancers types, such as ACC [18], NSCLC [102,103], CRC [19,104], prostate cancer (PCa) [105], and breast cancer [106], among others. Here, KIF11 is linked to non-small cell lung carcinoma.